Patterns and Predictors of Healthcare Use among Adolescent and Young Adult Cancer Survivors versus a Community Comparison Group
Healthcare use (HCU) during survivorship can mitigate adolescent and young adult (AYA) cancer survivors’ (aged 15–39 years) risk of medical and psychosocial late effects, but this is understudied. We surveyed 93 Australian AYA post-treatment cancer survivors (<i>M<sub>age</sub><...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
MDPI AG
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/ac3c50fd4f034afb8b09ccdd289f9328 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Healthcare use (HCU) during survivorship can mitigate adolescent and young adult (AYA) cancer survivors’ (aged 15–39 years) risk of medical and psychosocial late effects, but this is understudied. We surveyed 93 Australian AYA post-treatment cancer survivors (<i>M<sub>age</sub></i> = 22.0 years, SD = 3.5; 55.9% female) and a comparison sample of 183 non-matched AYAs (<i>M<sub>age</sub></i> = 19.7, SD = 3.2; 70.5% female) on their HCU, medication use, depression/anxiety, and general functioning. Relative to our comparison AYAs, a higher proportion of our survivor group reported medical HCU (community-delivered: 65.6% versus 47.0%, <i>p</i> = 0.003; hospital-delivered: 31.2% versus 20.3%, <i>p</i> = 0.044) and mental HCU (53.8% vs. 23.5%; <i>p</i> < 0.0001) in the past six months. A higher proportion of our survivors reported taking medications within the past six months than our comparison AYAs (61.3% vs. 42.1%, <i>p</i> = 0.003) and taking more types (<i>p</i> < 0.001). Vitamin/supplement use was most common followed by psychotropic medications. Our survivor group reported lower depression (<i>p</i> = 0.001) and anxiety symptoms (<i>p</i> = 0.003), but similar work/study participation (<i>p</i> = 0.767) to our comparison AYAs. Across groups, psychological distress was associated with higher mental HCU (<i>p</i> = 0.001). Among survivors, those who were female, diagnosed with brain/solid tumors and who had finished treatment more recently reported greater HCU. Future research should establish whether this level of HCU meets AYAs’ survivorship needs. |
|---|